Fig. 3From: Antitumor activity of vorinostat-incorporated nanoparticles against human cholangiocarcinoma cellsWestern blot analysis of Ac-histone H3 and HDAC expression after treatment with vorinostat or vorinostat-NPs. a expression of Ac-histone H3 and HDACs; b quantitation of Ac-histone H3 expression; c quantitation of HDAC expressionBack to article page